As such, we sought to explore the presence of anti-PAD4 and anti-PAD3/4 antibodies in the sputum and saliva of RA patients, as well as subjects at-risk for RA, and define their effect on PAD4 enzyme activity. This evidence concerns the gene PADI3 and rheumatoid arthritis.